Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2019 HTA Annual Report
      • 2020 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
      • Major Application
        • Expedited
          • COVID-19 Vaccines
          • Other COVID-19 Health Technologies
        • Urgent
        • General
      • Minor Application
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Call for Interested Parties
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2019 HTA Annual Report
      • 2020 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
      • Major Application
        • Expedited
          • COVID-19 Vaccines
          • Other COVID-19 Health Technologies
        • Urgent
        • General
      • Minor Application
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Call for Interested Parties
    • Topic Nomination

Preliminary Recommendation

preliminary recommendation for the inclusion of sambong 250mg tablets as anti-urolithiasis

Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-infection

PRELIMINARY RECOMMENDATION ON Dolutegravir (DTG)

Preliminary recommendation on Tenofovir/Lamivudine/Dolutegravir (TLD)

484531
Users Today : 820
This Month : 32483
Total Users : 484531
Your IP Address : 52.91.0.112
Philippine Standard Time:
✕

Philippine Society of Microbiology and Infectious Diseases (PSMID) releases Philippine COVID-19 Living Recommendations

View the document on their website: https://www.psmid.org/philippine-covid-19-living-recommendations/